Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04346173
Other study ID # Furlow with buccinator
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2018
Est. completion date March 1, 2020

Study information

Verified date April 2020
Source Alexandria University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

: Cleft palate is a congenital deformity caused by abnormal facial development during intra-uterine life. Worldwide, the prevalence of cleft lip/palate is about 1:1000 live births.

The levator vela palatini muscles are malpositioned sagittally, running postero-anteriorly and inserted onto the posterior edge of the hard palate in cleft palate patients . This configuration prevents the muscle from exerting its upward, backward, and lateral pull.

Various modalities have been described with major refinements over the past 30 years. Gradually, cleft surgeons began to appreciate the importance of dissection and retro-positioning of the levator muscle on improving speech outcomes.

Furlow was the first to describe the palatoplasty technique, in which the levator muscle is dissected and freely released from its abnormal position and retro-positioned in a Z-plasty lengthening technique without dissection on the hard palate. However , among the problems that have been raised concerning the Furlow palatoplasty is the limitation of the procedure in wide clefts. Furthermore, the possibility of higher fistula rate associated with the technique.

These considerations have led to modified palatal lengthening by buccinator myomucosal flaps which is this study working on.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date March 1, 2020
Est. primary completion date January 1, 2020
Accepts healthy volunteers No
Gender All
Age group 9 Months to 18 Months
Eligibility Inclusion Criteria:

- Patients in the age frame between 9 months and 18 months.

- Cleft palate alone or cleft lip and palate patients.

- Patients who have not done any previous palatal repair

- Haemoglobin level above 10 grams.

- Weight above 10 pounds.

Exclusion Criteria:

- Syndromic patients.

- Medically compromised patients contradicting operation.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
furlow z plasty with buccinator myomucosal flap
using furlow palatoplasty technique accompanied with addition of buccinator myomucosal flap for closure of primary unilateral cleft palate

Locations

Country Name City State
Egypt Faculty of Dentistry, Alexandria University Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Hams Hamed Abdelrahman

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary palatal lengthening measuring the length the palate will gain using this technique immediately postoperative